Whalegun
Home

AbbVie ABBV spent $750K on lobbying in Q3 2023 · Copyright, Health Issues and 2 more issues

Trade details

Type
Lobbying report
Amount
$750,000
Quarter
Q3 2023
Stock
AbbVie ABBV
Client
Abbvie
Reported
23/10/20

Up 25.0% from last quarter

What else happened in AbbVie around then

Filed or reported within 30 days of the trade day · 23/08/31~23/10/30

Abbvie's other lobbying reports

  • Abbvie

    LobbyingAbbVie

    $50K

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $60K

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $1.2M

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $60K

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $30K

    Reported 07/20

AbbVie ABBV spent $750K on lobbying in Q3 2023 · Copyright, Health Issues and 2 more issues | Whalegun